Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
Miguel MartinEva CarrascoÁlvaro Rodríguez-LescureRaquel AndrésSonia ServitjaAntonio AntónManuel Ruiz-BorregoBegoña BermejoÁngel GuerreroManuel RamosAna SantaballaMontserrat MuñozJosefina CruzSara Lopez-TarruellaJose I ChacónIsabel ÁlvarezPurificación MartínezJuan J MirallesÓscar PolonioCarlos JaraDavid Aguiar-BujandaPublished in: Breast cancer research and treatment (2023)
ClinTrials.gov: GEICAM/9906: NCT00129922; GEICAM/ 2003-10: NCT00129935 and GEICAM/ 2006-10: NCT00543127.
Keyphrases